Merck is set to remove cancer-causing chemical from top diabetes drugs
Last year, the pharmaceutical firm found potential carcinogens in some of its best-selling diabetes drugs – but the issue could be resolved in 2023.
by Robert Langreth and Cynthia Koons, bloomberg
Merck & Co., known as MSD outside the US, has discovered how its blockbuster diabetes medications have become contaminated with a potential carcinogen and believes it can resolve the problem by the end of the year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
MSD diabetes drug found to contain possible carcinogen
For subscribers
Moderna and MSD publicize promising study of cancer vaccine
For subscribers
